FDA Reviews Mirapex for Heart Failure Risk
The U.S. Food and Drug Administration (FDA) issued a safety announcement regarding a potential health hazard posed by Mirapex (pramipexole), which is used to treat Parkinson’s disease and restless legs syndrome. The FDA says recent studies suggest that the drug may increase the risk of potential heart failure in users but that further research is needed. The agency says it is working with manufacturer Boehringer Ingelheim Pharmaceuticals Inc. to clarify the risk of heart failure. The FDA is conducting an ongoing safety review of the